DATROWAY J Code: J9011

Drug & Product Overview

HCPCS Descriptor Injection, datopotamab deruxtecan-dlnk, 1 mg

HCPCS Added Date October 1, 2025

Manufacturer Daiichi Sankyo

Route of Administration Intravenous

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Injection, Powder, Lyophilized, For Solution

About DATROWAY

Datroway is a medication aligned to the HCPCS J Code: J9011 for billing, pricing, and reimbursement purposes in the United States. Classified under Oncology, it is administered via the intravenous route and manufactured by Daiichi Sankyo.

According to CMS Drug Use Information: This medication is used to treat certain types of cancer (such as breast, lung). It works by slowing or stopping the growth of cancer cells.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
65597-0801-01	Datroway	Daiichi Sankyo Inc.	100	100 MG / 5 ML

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

DATROWAY Pricing & Reimbursement

J9011 Private Payer Reimbursement

$52.88 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q4 2026

DATROWAY Claims Performance

Claims from Jan 2026 – Aug 2026

Claim Denial Rate 20.02%

Avg. Days to File 9.0days

Avg. Days to Pay 29.2days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J9011 claims analytics on FocalPoint →

DATROWAY CPT Administration Codes

CPT Code	Description
96413	Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415	Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)

Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

DATROWAY Medically Unlikely Edits (MUE)

The most billing units of J9011 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg.

Practitioner Office & Hospital Outpatient

600 units / day

= 600 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

DATROWAY Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Locally advanced or metastatic EGFR-mutated non-small cell lung cancer (NSCLC) Unresectable or metastatic triple-negative breast cancer (TNBC) Unresectable or metastatic, HR-positive, HER2-negative breast cancer

Frequently Asked Questions

Is there an available Datroway billing and coding guide?

Our team has not identified a manufacturer-published source of billing and coding information for DATROWAY.

Are there any available Datroway patient assistance programs?

DATROWAY patient assistance information can be found through Daiichi Sankyo Inc.. Visit Here →

Where can I find Datroway prescribing information?

Datroway prescribing information can be found through the link below. Visit Here →

Where can I find Datroway side effect information?

Datroway side effect information can be found at the link below. Visit Here →

Does billing Datroway require wastage modifiers?

CMS does not include DATROWAY (J9011) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J9011. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.